Macrophages Sequentially Change Their Functional Phenotype in Response to Changes in Microenvironmental Influences1
暂无分享,去创建一个
[1] C. Rabourdin-Combe,et al. Immature dendritic cell transdifferentiation into osteoclasts: a novel pathway sustained by the rheumatoid arthritis microenvironment. , 2004, Blood.
[2] Li Wu,et al. Are dendritic cells end cells? , 2004, Nature Immunology.
[3] Hua Tang,et al. Splenic stroma drives mature dendritic cells to differentiate into regulatory dendritic cells , 2004, Nature Immunology.
[4] J. Suttles,et al. Functional plasticity of macrophages: reversible adaptation to changing microenvironments , 2004, Journal of leukocyte biology.
[5] T. Nomura,et al. Distinct contribution of IL-6, TNF-alpha, IL-1, and IL-10 to T cell-mediated spontaneous autoimmune arthritis in mice. , 2004, The Journal of clinical investigation.
[6] G. Firestein. The T cell cometh: interplay between adaptive immunity and cytokine networks in rheumatoid arthritis. , 2004, The Journal of clinical investigation.
[7] Timothy P Plackett,et al. Aging and innate immune cells , 2004, Journal of leukocyte biology.
[8] L. Steinman. Immune Therapy for Autoimmune Diseases , 2004, Science.
[9] F. Balkwill. Cancer and the chemokine network , 2004, Nature Reviews Cancer.
[10] Marina Ziche,et al. Development of new drugs in angiogenesis. , 2004, Current drug targets.
[11] Lawrence Steinman,et al. Elaborate interactions between the immune and nervous systems , 2004, Nature Immunology.
[12] F. Brombacher,et al. Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology. , 2004, Immunity.
[13] H. Neumann,et al. Microglia: The Enemy Within? , 2003, Science.
[14] L. Sibley,et al. A novel population of Gr‐1+‐activated macrophages induced during acute toxoplasmosis , 2003, Journal of leukocyte biology.
[15] M. Triggiani,et al. The histamine-cytokine network in allergic inflammation. , 2003, The Journal of allergy and clinical immunology.
[16] Piero Carninci,et al. Genetic control of the innate immune response , 2003, BMC Immunology.
[17] D. Mosser,et al. The many faces of macrophage activation , 2003, Journal of leukocyte biology.
[18] S. Bernstein,et al. Human CD4+ T Cells Present Within the Microenvironment of Human Lung Tumors Are Mobilized by the Local and Sustained Release of IL-12 to Kill Tumors In Situ by Indirect Effects of IFN-γ1 , 2003, The Journal of Immunology.
[19] Bin Liu,et al. Role of Microglia in Inflammation-Mediated Neurodegenerative Diseases: Mechanisms and Strategies for Therapeutic Intervention , 2003, Journal of Pharmacology and Experimental Therapeutics.
[20] G. Laurent,et al. Adhesion Molecule–dependent Mechanisms Regulate the Rate of Macrophage Clearance During the Resolution of Peritoneal Inflammation , 2002, The Journal of experimental medicine.
[21] P. Allavena,et al. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. , 2002, Trends in immunology.
[22] U. Hanisch,et al. Microglia as a source and target of cytokines , 2002, Glia.
[23] P. Finan,et al. IL‐10 expression profiling in human monocytes , 2002, Journal of leukocyte biology.
[24] Peter J. Murray,et al. Shaping Gene Expression in Activated and Resting Primary Macrophages by IL-101 , 2002, The Journal of Immunology.
[25] John Parkinson,et al. IL-4 dependent alternatively-activated macrophages have a distinctive in vivo gene expression phenotype , 2002, BMC Immunology.
[26] G. Chrousos,et al. Stress Hormones, Proinflammatory and Antiinflammatory Cytokines, and Autoimmunity , 2002, Annals of the New York Academy of Sciences.
[27] David M. Mosser,et al. Cutting Edge: Biasing Immune Responses by Directing Antigen to Macrophage Fcγ Receptors1 , 2002, The Journal of Immunology.
[28] Noam Brown,et al. The role of tumour‐associated macrophages in tumour progression: implications for new anticancer therapies , 2002, The Journal of pathology.
[29] E. Pearce,et al. Differential Regulation of Nitric Oxide Synthase-2 and Arginase-1 by Type 1/Type 2 Cytokines In Vivo: Granulomatous Pathology Is Shaped by the Pattern of l-Arginine Metabolism1 , 2001, The Journal of Immunology.
[30] Kristi Kincaid,et al. M-1/M-2 Macrophages and the Th1/Th2 Paradigm1 , 2000, The Journal of Immunology.
[31] Constantin E. Orfanos,et al. Alternative versus Classical Activation of Macrophages , 2000, Pathobiology.
[32] D. Mullins,et al. Tumor‐induced immune dysfunction: the macrophage connection , 1998, Journal of leukocyte biology.
[33] S. Khoury,et al. Kinetics of expression of costimulatory molecules and their ligands in murine relapsing experimental autoimmune encephalomyelitis in vivo. , 1998, Journal of immunology.
[34] M. Munder,et al. Alternative metabolic states in murine macrophages reflected by the nitric oxide synthase/arginase balance: competitive regulation by CD4+ T cells correlates with Th1/Th2 phenotype. , 1998, Journal of immunology.
[35] S. Goerdt,et al. Differences in angiogenic potential of classically vs alternatively activated macrophages. , 1997, Immunobiology.
[36] A. Meyerhans,et al. Monocyte-derived dendritic cells represent a transient stage of differentiation in the myeloid lineage. , 1997, Immunobiology.
[37] J. Suttles,et al. T cell signaling of macrophage function in inflammatory disease. , 1997, Frontiers in bioscience : a journal and virtual library.
[38] T. Olsson,et al. Cytokine production in the central nervous system of Lewis rats with experimental autoimmune encephalomyelitis: dynamics of mRNA expression for interleukin-10, interleukin-12, cytolysin, tumor necrosis factor α and tumor necrosis factor β , 1995, Journal of Neuroimmunology.
[39] J. Suttles,et al. T-Cell Signaling of Macrophage Activation: Cell Contact-Dependent and Cytokine Signals , 1995 .
[40] G. Trinchieri,et al. Stimulatory and inhibitory effects of interleukin (IL)-4 and IL-13 on the production of cytokines by human peripheral blood mononuclear cells: priming for IL-12 and tumor necrosis factor alpha production , 1995, The Journal of experimental medicine.
[41] F. Herrmann,et al. Discordant adaptation of human peritoneal macrophages to stimulation by lipopolysaccharide and the synthetic lipid A analogue SDZ MRL 953. Down-regulation of TNF-alpha and IL-6 is paralleled by an up-regulation of IL-1 beta and granulocyte colony-stimulating factor expression. , 1994, Journal of immunology.
[42] C. Manthey,et al. Dissociation of lipopolysaccharide (LPS)-inducible gene expression in murine macrophages pretreated with smooth LPS versus monophosphoryl lipid A , 1993, Infection and immunity.
[43] S Gordon,et al. Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation , 1992, The Journal of experimental medicine.
[44] S. Gordon,et al. Macrophages in tissues and in vitro. , 1992, Current opinion in immunology.
[45] D. Adams,et al. Gene Regulation in Macrophage Activation: Differential Regulation of Genes Encoding for Tumor Necrosis Factor, Interleukin‐1, JE, and KC by interferon‐γ and Lipopolysaccharide , 1990, Journal of leukocyte biology.
[46] B. Brüne,et al. PPAR γ – an Important Regulator of Monocyte / Macrophage Function , 2004 .
[47] R. Diegelmann,et al. Wound healing: an overview of acute, fibrotic and delayed healing. , 2004, Frontiers in bioscience : a journal and virtual library.
[48] S. Gordon. Alternative activation of macrophages , 2003, Nature Reviews Immunology.
[49] H. Neumann,et al. Neuroscience. Microglia: the enemy within? , 2003, Science.
[50] B. Brüne,et al. PPARgamma--an important regulator of monocyte/macrophage function. , 2003, Archivum immunologiae et therapiae experimentalis.
[51] C. Janeway,et al. Innate immune recognition. , 2002, Annual review of immunology.
[52] H. Ziegler-Heitbrock,et al. Interleukin-10 is upregulated in LPS tolerance. , 1995, Journal of inflammation.